Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPSV23 Vaccine in Severe COPD Patients on High-Dose ICS
NCT01381367Phase 4Completed
- Sponsor
- Far Eastern Memorial Hospital
- Start
- Feb 2009
- Primary completion
- Jun 2011
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of 23-valent pneumococcal polysaccharide vaccine in Pneumococcal pneumonia (PP), sponsored by Far Eastern Memorial Hospital. Started Feb 2009; status: completed.
02
Drugs
23-valent pneumococcal polysaccharide vaccine
03
Conditions
Pneumococcal pneumonia (PP)
Beyond the preview
Go deeper on NCT01381367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01381367.